COVID19 Severity Prediction and Health Services Research Evaluation

CompletedOBSERVATIONAL
Enrollment

380,000

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

December 30, 2022

Study Completion Date

December 31, 2022

Conditions
Covid19
Interventions
OTHER

Predictors adverse evolution

Predictors adverse evolution in all hospital participant admitted patients

OTHER

Predictors of health care provide

Predictors of death, unequity, variability in process of care, cost in all COVID positive patients form the Basque Country

Trial Locations (1)

48960

Hospital Galdakao-Usansolo, Galdakao

All Listed Sponsors
collaborator

Hospital Costa del Sol

OTHER

collaborator

Hospital del Mar

OTHER

collaborator

University Hospital of the Nuestra Señora de Candelaria

OTHER

collaborator

Instituto de Salud Carlos III

OTHER_GOV

collaborator

Hospital Universitario Araba

OTHER

collaborator

Biocruces Bizkaia Health Research Institute

OTHER_GOV

collaborator

Hospital de Basurto

OTHER

collaborator

Hospital Donostia

OTHER

lead

Hospital Galdakao-Usansolo

OTHER_GOV

NCT04463706 - COVID19 Severity Prediction and Health Services Research Evaluation | Biotech Hunter | Biotech Hunter